Dr. Gabriel Kremmidiotis, Ph.D., serves as Vice President Research and Development of Bionomics Limited. He is a Molecular geneticist and immunologist Dr. Gabriel Kremmidiotis joined the Company as Head of Bioinformatics in January 2002 and his role has since expanded to Vice President Discovery Research. Formerly Senior Medical Scientist at the Department of Cytogenetics & Molecular Genetics at the Women & Children Hospital in Adelaide, Dr. Kremmidiotis has several patent inventions on breast cancer tumour suppressor genes, including Bionomics' BNO 64 and BNO 1 genes as well as other tumour suppressor genes
Kremmidiotis has a Ph.D and a BS from Flinders University of South Australia and a BS from The University of Melbourne. He has published research findings in 23 internationallyrecognised scientific publications including Cell, Human Molecular Genetics and American Journal of Human Genetics, and is a member of the Human Genetics Society of Australasia.
Management Efficency
The company has return on total asset (ROA) of (6.29) % which means that it has lost $6.29 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (13.47) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.09 M in total debt with debt to equity ratio (D/E) of 0.04 which may suggest the company is not taking enough advantage from borrowing. Bionomics Ltd has Current Ratio of 4.42 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Bionomics Limited, a biotechnology company, engages in the discovery and development of therapeutics for the treatment of cancer and disorders of the central nervous system in Australia and France. Bionomics Ltd [BNO] is traded on Australian Securities Exchange in Australia. It is located in Thebarton, SA and employs 11 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
OTC
Frankfurt
Australian
